PH12022550661A1 - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- PH12022550661A1 PH12022550661A1 PH1/2022/550661A PH12022550661A PH12022550661A1 PH 12022550661 A1 PH12022550661 A1 PH 12022550661A1 PH 12022550661 A PH12022550661 A PH 12022550661A PH 12022550661 A1 PH12022550661 A1 PH 12022550661A1
- Authority
- PH
- Philippines
- Prior art keywords
- sulfate
- pharmaceutical composition
- chondroitin
- nasal polyp
- shrinking
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Otolaryngology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019170955 | 2019-09-20 | ||
| PCT/JP2020/035438 WO2021054440A1 (ja) | 2019-09-20 | 2020-09-18 | 医薬組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12022550661A1 true PH12022550661A1 (en) | 2023-03-27 |
Family
ID=74883058
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH1/2022/550661A PH12022550661A1 (en) | 2019-09-20 | 2020-09-18 | Pharmaceutical composition |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220347093A1 (https=) |
| EP (1) | EP4032535A4 (https=) |
| JP (1) | JP7313019B2 (https=) |
| CN (3) | CN114650828B (https=) |
| AU (1) | AU2020349263B2 (https=) |
| BR (1) | BR112022003464A2 (https=) |
| CA (1) | CA3154360C (https=) |
| MY (1) | MY206715A (https=) |
| PH (1) | PH12022550661A1 (https=) |
| WO (1) | WO2021054440A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3144752A1 (fr) * | 2023-01-10 | 2024-07-12 | Song Huang | Utilisation de polysulfate de pentosane pour le traitement de la toux seche |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3497209B2 (ja) | 1993-08-24 | 2004-02-16 | 生化学工業株式会社 | 硫酸化糖の脱硫酸化方法 |
| JP3512277B2 (ja) | 1995-10-05 | 2004-03-29 | 有限会社ジーオーメディカルサービス | 鼻茸治療・予防剤 |
| JPH10203988A (ja) | 1997-01-27 | 1998-08-04 | Meiji Milk Prod Co Ltd | 鼻茸および鼻粘膜の浮腫性病変の治療剤 |
| JPH11335288A (ja) * | 1998-05-20 | 1999-12-07 | Maruho Co Ltd | アレルギー性疾患の予防または治療薬 |
| WO2000069917A1 (fr) * | 1999-05-18 | 2000-11-23 | Maruho Kabushikikaisha | Compositions medicinales destinees a inhiber le systeme kallikreine-kinine ou la phospholipase a¿2? |
| EP1922076A4 (en) | 2005-08-03 | 2013-01-23 | Morria Biopharmaceuticals | USE OF LIPID CONJUGATES IN CYSTIC FIBROSIS AND ITS APPLICATIONS |
| US20140005115A1 (en) * | 2005-11-17 | 2014-01-02 | Yissum Research Development Company | Lipid conjugates in the treatment of bronchitis |
| US8859524B2 (en) * | 2005-11-17 | 2014-10-14 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Lipid conjugates in the treatment of chronic rhinosinusitis |
| CA2790682C (en) | 2010-03-03 | 2020-11-24 | Neocutis Sa | Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds |
| CN111437387B (zh) | 2013-06-21 | 2024-10-01 | 赛诺菲生物技术公司 | 通过施用il-4r拮抗剂治疗鼻息肉症的方法 |
| JP6637587B2 (ja) * | 2015-08-04 | 2020-01-29 | ズートツッカー アーゲー | 副鼻腔炎に対するイヌリンの予防的使用 |
-
2020
- 2020-09-18 MY MYPI2022001387A patent/MY206715A/en unknown
- 2020-09-18 US US17/760,901 patent/US20220347093A1/en active Pending
- 2020-09-18 CN CN202080064874.7A patent/CN114650828B/zh active Active
- 2020-09-18 AU AU2020349263A patent/AU2020349263B2/en active Active
- 2020-09-18 JP JP2021546977A patent/JP7313019B2/ja active Active
- 2020-09-18 CA CA3154360A patent/CA3154360C/en active Active
- 2020-09-18 CN CN202411053759.6A patent/CN118976045A/zh active Pending
- 2020-09-18 EP EP20864928.5A patent/EP4032535A4/en not_active Withdrawn
- 2020-09-18 WO PCT/JP2020/035438 patent/WO2021054440A1/ja not_active Ceased
- 2020-09-18 CN CN202410519891.5A patent/CN118416094A/zh active Pending
- 2020-09-18 BR BR112022003464A patent/BR112022003464A2/pt unknown
- 2020-09-18 PH PH1/2022/550661A patent/PH12022550661A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4032535A1 (en) | 2022-07-27 |
| CN114650828A (zh) | 2022-06-21 |
| CA3154360C (en) | 2024-01-23 |
| WO2021054440A1 (ja) | 2021-03-25 |
| AU2020349263B2 (en) | 2023-08-17 |
| CA3154360A1 (en) | 2021-03-25 |
| BR112022003464A2 (pt) | 2022-05-24 |
| CN118976045A (zh) | 2024-11-19 |
| CN118416094A (zh) | 2024-08-02 |
| JPWO2021054440A1 (https=) | 2021-03-25 |
| US20220347093A1 (en) | 2022-11-03 |
| MY206715A (en) | 2025-01-03 |
| EP4032535A4 (en) | 2023-10-25 |
| JP7313019B2 (ja) | 2023-07-24 |
| AU2020349263A1 (en) | 2022-04-14 |
| CN114650828B (zh) | 2024-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2020119390A (ru) | Применение каннабиноидов при лечении приступов, связанных с синдромом леннокса-гасто | |
| Chen et al. | Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules | |
| MX2021000861A (es) | Fucanos de alto peso molecular para tratar adhesiones fibrosas y otras enfermedades y padecimientos. | |
| MY198582A (en) | Pentosan polysulfate, pharmaceutical composition, and anticoagulant | |
| MX386086B (es) | Composicion de cannabis | |
| BR112014005134A2 (pt) | composição farmacêutica de dissolução rápida | |
| CA2286552A1 (en) | Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine | |
| NZ603479A (en) | Chitosan composition | |
| BR112018002466A2 (pt) | proteção de conteúdo aplicado em hardware para unidades de processamento gráfico | |
| GB2554296A (en) | Antithrombin-heparin compositions and methods | |
| PH12022550661A1 (en) | Pharmaceutical composition | |
| PH12019502676A1 (en) | Moisturizing topical preparation | |
| JP2016108327A5 (https=) | ||
| PH12019550138A1 (en) | Pharmaceutical combinations for treating cancer | |
| BR112021023845A2 (pt) | Complexos macromoleculares de fungicida de ditiocarbamato | |
| BR112021019187A2 (pt) | Método para repolarização de um macrófago associado a tumor de m2 a m1, e, composto para repolarização de um macrófago associado a tumor de m2 a m1 | |
| MX387286B (es) | Composicion sinergica para el mantenimiento de un equilibrio saludable de la microflora. | |
| WO2016056026A3 (en) | Synergistic composition for osteoarthritis | |
| WO2021074649A3 (en) | Methods of promoting scfa production by gut microbiota | |
| PH12019500511A1 (en) | Detergent compositions comprising ultra-low molecular weight polysaccharides | |
| BR102016028651A2 (pt) | polissacarídeos modificados. | |
| PH12020550775A1 (en) | Pentosan polysulfate and medicine containing pentosan polysulfate | |
| WO2019125330A3 (en) | Nasal decongestant compositions comprising dexpanthenol and sodium hyaluronate | |
| BR112015022243A2 (pt) | dihidroxipropil celulose etilsulfonada reticulada | |
| PT3257516T (pt) | Composição farmacêutica compreendendo cetraria islandica ach., hialuronato de sódio e uma solução salina para tratamento de doenças do sistema respiratório |